Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug is administered orally as a disodium salt, and is a prodrug of the active compound tamatinib (R-406), which is an inhibitor of the enzyme spleen tyrosine kinase (Syk), hence it is an syk inhibitor.

CAS：901119-35-5
中文别名：
英文别名：R788 compound;Fostamatinib;Fostamatinib (R788);
分子式：C23H26FN6O9P
分子量：580.46
精确质量：580.148
Psa：199.76
Logp：2.6544

MDL号：MFCD16628163

密度：1.5±0.1g/cm3
沸点：814.2±75.0°Cat760mmHg
闪点：446.2±37.1°C
蒸汽压：0.0±3.1mmHgat25°C
折射率：1.629
储存条件：-20°C